US might administer half doses of Moderna’s COVID-19 vaccine to accelerate rollout

The U.S. is considering administering shots that contain half the recommended dose of Moderna’s COVID-19 vaccine to expedite the vaccine rollout process, Moncef Slaoui, PhD, chief scientific advisor to Operation Warp Speed, said during a Jan. 4 interview on CBS‘ Face the Nation.

Advertisement

Dr. Slaoui said data shows a half dose of Moderna’s COVID-19 vaccine induces an “identical immune response” to the recommended full 100 microgram dose for people ages 18 to 55.

He also said the federal government is in discussions with Moderna and with the FDA to start administering half doses of Moderna’s vaccine; that decision is ultimately up to the FDA.

More articles on pharmacy:
West Virginia clinic gives 42 patients antibody cocktail instead of COVID-19 vaccine
Pfizer vs. Moderna COVID-19 vaccine: What’s the same & what’s different
Operation Warp Speed chief on vaccine distribution: ‘We know that it should be better’

 

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.